Expanded Newborn Screening Panel - 7 Disorders and TMS and Hemoglobinopathies - (Outlab)
What does Expanded Newborn Screening Panel - 7 Disorders and TMS and Hemoglobinopathies - (Outlab) measure?
This newborn screening panel evaluates blood markers associated with seven inherited metabolic disorders using tandem mass spectrometry (TMS), along with markers for hemoglobin variants and hemoglobinopathies. It may be used to identify newborns who could benefit from further evaluation for certain metabolic or blood-related conditions before symptoms develop. Screening results do not confirm a diagnosis and may require confirmatory testing.
This overview is educational. Use the recorded preparation, sample and lab-partner details below for collection guidance, and confirm any missing information before collection.
Compare eligible lab partners
Prices, report times and availability are shown from the catalog records for each eligible partner.
- Sample for analysis
- Confirm with the collection team
- Report time
- To be confirmed
Preparation and specimen requirements can vary by test and laboratory. Follow the instructions shown for your selected partner and any advice from your healthcare professional.